BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 23414366)

  • 1. Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.
    Kingham E; Oreffo RO
    ACS Nano; 2013 Mar; 7(3):1867-81. PubMed ID: 23414366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and future challenges of induced pluripotent stem cells.
    Ohnuki M; Takahashi K
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives of germ cell development in vitro in mammals.
    Hayashi K; Saitou M
    Anim Sci J; 2014 Jun; 85(6):617-26. PubMed ID: 24725251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of nanomaterials on stem cell differentiation: designing an appropriate nanobiointerface.
    Ilie I; Ilie R; Mocan T; Bartos D; Mocan L
    Int J Nanomedicine; 2012; 7():2211-25. PubMed ID: 22619557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will SCNT-ESCs be better than iPSCs for personalized regenerative medicine?
    Sancho-Martinez I; Izpisua Belmonte JC
    Cell Stem Cell; 2013 Aug; 13(2):141-2. PubMed ID: 23910080
    [No Abstract]   [Full Text] [Related]  

  • 8. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogrammed cells for disease modeling and regenerative medicine.
    Cherry AB; Daley GQ
    Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
    Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current progress and potential practical application for human pluripotent stem cells.
    Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
    Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomaterial aided differentiation and maturation of induced pluripotent stem cells.
    Velmurugan BK; Bharathi Priya L; Poornima P; Lee LJ; Baskaran R
    J Cell Physiol; 2019 Jun; 234(6):8443-8454. PubMed ID: 30565686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turning straw into gold: directing cell fate for regenerative medicine.
    Cohen DE; Melton D
    Nat Rev Genet; 2011 Apr; 12(4):243-52. PubMed ID: 21386864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerative therapy for hypothyroidism: Mechanisms and possibilities.
    Hollenberg AN; Choi J; Serra M; Kotton DN
    Mol Cell Endocrinol; 2017 Apr; 445():35-41. PubMed ID: 27876515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult stem cells: hopes and hypes of regenerative medicine.
    Dulak J; Szade K; Szade A; Nowak W; Józkowicz A
    Acta Biochim Pol; 2015; 62(3):329-37. PubMed ID: 26200199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.